Modified MVAC as a Second-Line Treatment for Patients with Metastatic Urothelial Carcinoma after Failure of Gemcitabine and Cisplatin Treatment

PURPOSE: There is no established standard second-line chemotherapy for patients with advanced or metastatic urothelial carcinoma (UC) who failed gemcitabine and cisplatin (GC) chemotherapy. This study was conducted in order to investigate the efficacy and toxicity of modified methotrexate, vinblasti...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jung Hyun, Kang, Sung Gu, Kim, Seung Tae, Kang, Seok Ho, Choi, In Keun, Park, Young Je, Oh, Sang Chul, Sung, Deuk Jae, Seo, Jae Hong, Cheon, Jun, Shin, Sang Won, Kim, Yeul Hong, Kim, Jun Suk, Park, Kyong Hwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022826/
https://www.ncbi.nlm.nih.gov/pubmed/24851109
http://dx.doi.org/10.4143/crt.2014.46.2.172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022826/
https://www.ncbi.nlm.nih.gov/pubmed/24851109
http://dx.doi.org/10.4143/crt.2014.46.2.172

Ejemplares similares